Hypertrophic Cardiomyopathy is one of the commonest genetic cardiac abnormalities involving cardiac sarcomeres. Among the different phenotypic variants, apical hypertrophic cardiomyopathy is usually considered to be benign. Coronary microvascular abnormalities have been reported in such cases though frank infarct is quite rare. Here we have reported a teenage boy of apical hypertrophic cardiomyopathy with microvascular infarction associated with elevated LP (a) and serum homocysteine.
.Septal and posterior wall diameter was 14mm each whereas the apex was 17 mm in diameter. There was no SAM (systolic anterior motion of mitral valve leaflet), significant LV outflow or mid cavity gradient. His Hemogram, fasting blood glucose, blood urea, creatinine and electrolytes were normal. Lipid profile showed Total cholesterol-152mg/dl, LDL-108, VLDL-29, TG-145 and HDL was 25mg/dl. Lipoprotein (a) was 50.7mg/dl (normal-<30mg/dl) and serum homocysteine level 20.54 micromol/L(3.7-13.9) were high. Subsequently coronary angiogram and LV angiogram was performed that showed normal epicardial coronary arteries and a spade shaped LV angiogram with apical obliteration (Fig 3,4,5) . In view of the positive myocardial biomarkers, ECG changes and symptoms a diagnosis of non ST segment MI was made and patient was put on treatment accordingly with excellent recovery. However normal epicardial coronaries, ECG changes and echocardiographic and LV angiographic findings suggested diagnosis of microvascular myocardial infraction and apical hypertrophic cardiomyopathy in this case.
Discussion
Hypertrophic Cardiomyopathy is the most common genetic cardiovascular diseases caused by a multitude of mutatations affecting genes encoding cardiac sarcomeres. 1 Apical HCM is a variant with predominant involvement of the apex of the heart, was first described in Japanese males in 1976, 2 and estimated to represent25% of Japanese patients with HCM. Segmental wall thickening mostly confined to the distal Genetic relation between typical HCM and apical HCM is incompletely understood. 3 Regional myocardial ischemia in the absence of coronary artery disease is not uncommon in HCM as demonstrated by stress ECG, myocardial perfusion imaging etc. Microvascular dysfunction represents a predisposing factor JM Vol. 14, No. 1
Apical Hypertrophic Cardiomyopathy and Myocardial Infarction in a Young Adult, A Rare Combination for myocardial ischaemia which is a common feature of hypertrophic cardiomyopathy.It is a strong independent predictor of clinical deterioration and death.Severe microvascular dysfunction is often present in patients with no symptoms and may precede clinical deterioration by years. 4 Severe impairment of coronary vasodilator response to dypiridamole infusion in PET scan is strongly associated with long term adverse LV remodelling and systolic dysfunction in HCM patients. 5 In hypertrophic cardiomyopathy abnormal intramural coronary arteries are characterized by thickening of vessel wall due to proliferation of medial and intimal components particularly smooth muscle cells and collagen. They may be located in ventricular septum,anterior left ventricular free wall or posterior free wall. 6 Potential cause ofmicrovascularangina may include microvascular abnormalities and inadequate capillary densities in comparison to increased LV mass. Abnormal intramural coronaries with increased intimal and medial thickening and myocardial bridging, septal perforator artery compression, coronary artery spasm, elevated filling pressures related to impaired diastolic relaxation and increased oxygen demand due to dynamic LV outflow gradients are also potential mechanism of myocardial ischemia. 7 In general, patients with apical HCM have a benign course. Symptoms of angina and exertionaldyspnea are well controlled with agents like beta blockers and calcium channel blockers. About half of the patients remain asymptomatic on long term. There have been reports of myocardial infarction, atrial fibrillation or stroke in about one third patients. 8 KyungTae Jung et al reported a case of apical hypertrophic cardiomyopathy with multiple coronary artery thrombosis. 9 Homocysteine is a risk factor for cardiovascular disease but treatment with B vitamins didn't lower risk of recurrent cardiovascular disease rather it was harmful 10 .Kamstrup et al conducted Mendelian randomization study to assess LP(a) and myocardial infarction and found that LP(a) gene KIR-2 variants are inversely associated with risk of myocardial infarction.
However combination of apical hypertrophic cardiomyopathy with normal coronaries and microvascular infarction in such a young individual has not been reported. Moreover presence of traditional risk factors of south Asian like low HDL, increased LP (a) and increased homocysteine level in our case is unique and might have contributed to microvascular abnormalities in addtition to the microvascular defect inherent to hypertrophic cardiomyopathies.
Conclusion
Hypertrophic cardiomyopathy, even its apical variant is not a completely benign disease, and microvascular dysfunction is a well recognized entity. In combination with pre-existing risk factors, acute coronary events may occur even in young individuals where such possibilities are thought to be extremely rare. Aggressive management of risk factors are needed in such individuals to avoid coronary events.
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